Skip to Content

G. Brandon Gunn, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Medical Director, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center - Proton Therapy Center, Houston, TX

Education & Training

Degree-Granting Education

2004 Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX, MD, Medicine
1996 Baylor University, Waco, TX, BA, Biology

Postgraduate Training

6/2005-6/2009 Clinical Residency, Radiation Oncology, University of Texas Medical Branch, Galveston, TX
6/2004-6/2005 Transitional Internship, Christus St. Joseph Hospital, Houston, TX

Board Certifications

5/2010 American Board of Radiology, Radiation Oncology

Honors and Awards

2009 Most Outstanding Overall Resident for 2008-2009, University of Texas Medical Branch, Galveston, TX
2008-2009 Chief Resident, Radiation Oncology, University of Texas Medical Branch, Galveston, Texas
2005 Most Outstanding Resident, Christus St. Joseph Hospital, Transitional Internship Program, Houston, Texas
2004 Valedictorian of Medical School Class, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, Texas
2003 Alpha Omega Alpha, Medical Honor Society

Selected Publications

Peer-Reviewed Original Research Articles

1. Gunn GB, Blanchard P, Garden AS, Zhu XR, Fuller CD, Mohamed AS, Morrison WH, Phan J, Beadle BM, Skinner HD, Sturgis EM, Kies MS, Hutcheson KA, Rosenthal DI, Mohan R, Gillin MT, Frank SJ. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys 95(1):360-7, 5/2016. e-Pub 2/2016. PMID: 27084653.
2. Bhattasali O, Holliday E, Kies MS, Hanna EY, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Fuller CD, Zhu XR, Frank SJ. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: A series of 9 cases and a critical review of the literature. Head Neck 38 Suppl 1:E1472-80, 4/2016. e-Pub 11/11/2015. PMID: 26561041.
3. Takiar V, Ma D, Garden AS, Li J, Rosenthal DI, Beadle BM, Frank SJ, Fuller CD, Gunn GB, Morrison WH, Hutcheson K, El-Naggar AK, Gold KA, Kupferman ME, Phan J. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy. Head Neck 38 Suppl 1:E925-33, 4/2016. e-Pub 7/18/2015. PMID: 25994561.
4. Bishop AJ, Garden AS, Gunn GB, Rosenthal DI, Beadle BM, Fuller CD, Levy LB, Gillenwater AM, Kies MS, Esmaeli B, Frank SJ, Phan J, Morrison WH. Merkel Cell Carcinoma of the Head and Neck: Favorable Outcomes with Radiotherapy. Head Neck 38 Suppl 1:E452-8, 4/2016. e-Pub 7/14/2015. PMID: 25645649.
5. Cabanillas ME, Dadu R, Hu MI, Lu C, Gunn GB, Grubbs EG, Lai SY, Williams MD. Thyroid Gland Malignancies. Hematol Oncol Clin North Am 29(6):1123-43, 12/2015. PMID: 26568552.
6. Gunn GB, Hansen CC, Garden AS, Fuller CD, Mohamed AS, Morrison WH, Frank SJ, Beadle BM, Phan J, Chronowski GM, Sturgis EM, Lewis CM, Lu C, Hutcheson KA, Mendoza TR, Cleeland CS, Rosenthal DI. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol 117(1):132-8, 10/2015. e-Pub 9/21/2015. PMCID: PMC4762263.
7. Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, Frank SJ, Beadle BM, Phan J, Sturgis EM, Zafereo ME, Weber RS, Rosenthal DI, Gunn GB. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: Quantitative image analysis of post-radiotherapy response. Oral Oncol 51(2):195-201, 2/2015. e-Pub 11/28/2014. PMCID: PMC4502963.
8. Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, Morrison WH, Kies MS, Rosenthal DI, Sturgis EM. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Cancer 120(19):3082-8, 10/1/2014. e-Pub 6/4/2014. PMCID: PMC4172550.
9. Sheu T, Fuller CD, Mendoza TR, Garden AS, Morrison WH, Beadle BM, Phan J, Frank SJ, Hanna EY, Lu C, Cleeland CS, Rosenthal DI, Gunn GB. Nomogram for Predicting Symptom Severity During Radiation Therapy for Head and Neck Cancer. Otolaryngol Head Neck Surg 151(4):619-26, 10/2014. e-Pub 8/7/2014. PMCID: PMC4184965.
10. Frank SJ, Cox JD, Gillin M, Mohan R, Garden AS, Rosenthal DI, Gunn GB, Weber RS, Kies MS, Lewin JS, Munsell MF, Palmer MB, Sahoo N, Zhang X, Liu W, Zhu XR. Multifield Optimization Intensity Modulated Proton Therapy for Head and Neck Tumors: A Translation to Practice. Int J Radiat Oncol Biol Phys 89(4):846-53, 7/15/2014. e-Pub 5/24/2014. PMCID: PMC4171724.
11. Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of Symptom Burden During Radiation Therapy or Concurrent Chemoradiation for Head and Neck Cancer: A Prospective Analysis Using the MD Anderson Symptom Inventory–Head and Neck Module. Cancer 120(13):1975-84, 7/1/2014. e-Pub 4/7/2014. PMCID: PMC4095802.
12. Kocak-Uzel E, Gunn GB, Colen RR, Kantor ME, Mohamed AS, Schoultz-Henley S, Mavroidis P, Frank SJ, Garden AS, Beadle BM, Morrison WH, Phan J, Rosenthal DI, Fuller CD. Beam path toxicity in candidate organs-at-risk: Assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy. Radiother Oncol 111(2):281-8, 5/2014. e-Pub 4/17/2014. PMCID: PMC4063998.
13. Shi Q, Mendoza TR, Gunn GB, Wang XS, Rosenthal DI, Cleeland CS. Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res 22(9):2331-9, 11/2013. e-Pub 3/9/2013. PMCID: PMC3718875.
14. Gunn GB, Mendoza TR, Fuller CD, Gning I, Frank SJ, Beadle BM, Hanna EY, Lu C, Cleeland CS, Rosenthal DI. High Symptom Burden Prior to Radiation Therapy for Head and Neck Cancer: A Patient-Reported Outcomes Study. Head Neck 35(10):1490-8, 10/2013. e-Pub 11/20/2012. PMCID: PMC3788079.
15. Gunn GB, Debnam JM, Fuller CD, Morrison WH, Frank SJ, Beadle BM, Sturgis EM, Glisson BS, Phan J, Rosenthal DI, Garden AS. The Impact of Radiographic Retropharyngeal Adenopathy in Oropharyngeal Cancer. Cancer 119(17):3162-9, 9/1/2013. e-Pub 6/3/2013. PMCID: PMC3775996.
16. Sanguineti G, Rao N, Gunn GB, Ricchetti F, Fiorino C.. Predictors of PEG dependence after IMRT±chemotherapy for oropharyngeal cancer. Radiother Oncol 107(3), Jun 14 2013, 6/2013. e-Pub 6/2013. PMID: 23773408.
17. Garden AS, Dong L, Morrison WH, Stugis EM, Glisson BS, Frank SJ, Beadle BM, Gunn GB, Schwartz DL, Kies MS, Weber RS, Ang KK, Rosenthal DI. Patterns of Disease Recurrence Following Treatment of Oropharyngeal Cancer With Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 85(4):941-7, 3/15/2013. e-Pub 9/11/2012. PMID: 22975604.
18. Garden AS, Kies MS, Morrison WH, Weber RS, Frank SJ, Glisson BS, Gunn GB, Beadle BM, Ang KK, Rosenthal DI, Sturgis EM. Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol 8(1):21, 2013. e-Pub 1/29/2013. PMCID: PMC3576243.
19. Hutcheson KA, Lewin JS, Barringer DA, Lisec A, Gunn GB, Moore MW, Holsinger FC. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer 118(23):5793-9, 12/1/2012. e-Pub 5/17/2012. PMCID: PMC4034519.
20. Sanguineti G, Sormani MP, Marur S, Gunn GB, Rao N, Cianchetti M, Ricchetti F, McNutt T, Wu B, Forastiere A. Effect of Radiotherapy and Chemotherapy on the Risk of Mucositis during Intensity-Modulated Radiation Therapy for Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys 83(1):235-42, 5/1/2012. e-Pub 11/19/2011. PMID: 22104358.
21. Chronowski GM, Garden AS, Morrison WH, Frank SJ, Schwartz DL, Shah SJ, Beadle BM, Gunn GB, Kupferman ME, Ang KK, Rosenthal DI. Unilateral Radiotherapy for the Treatment of Tonsil Cancer. Int J Radiat Oncol Biol Phys 83(1):204-9, 5/1/2012. e-Pub 10/20/2011. PMID: 22019242.
22. Gunn GB, Koukourakis MI, Mendoza TR, Cleeland CS, Rosenthal DI. Linguistic validation of the Greek M.D. Anderson symptom Inventory – Head and Neck Module. Forum Clin Oncol 3(1):29-31,, 3/2012. PMCID: PMC3576859.
23. Sanguineti G, Gunn GB, Parker BC, Endres EJ, Zeng J, Fiorino C. Weekly Dose-Volume Parameters of Mucosa and Constrictor Muscles Predict the Use of Percutaneous Endoscopic Gastrostomy During Exclusive Intensity-Modulated Radiotherapy for Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys 79(1):52-59, 1/1/2011. e-Pub 4/24/2010. PMID: 20418027.
24. Gunn GB, Endres EJ, Parker B, Sormani MP, Sanguineti G. A Phase I-II Study of altered fractionated IMRT alone for intermediate T-Stage oropharyngeal carcinoma. Strahlenther Onkol 9(186):489-95, 9/2010. e-Pub 8/30/2010. PMID: 20803186.
25. Gunn GB, Anderson KE, Patel AJ, Gallegos J, Hallberg CK, Sood G, Hatch SS, Sanguineti G. Severe radiation therapy-related soft tissue toxicity in a patient with porphyria cutanea tarda: A literature review. Head Neck 32(8):1112-7, 8/2010. e-Pub 6/2009. PMCID: PMC2891307.
26. Sanguineti G, Gunn GB, Endres EJ, Chaljub G, Cheruvu P, Parker B. Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 73(3):737-46, 11/1/2008. e-Pub 5/15/2008. PMID: 18486356.
27. Sanguineti G, Endres EJ, Gunn GB, Parker B. Is there a 'mucosa sparing' benefit of IMRT for head and neck cancer? Int J Radiat Oncol Biol Phys 66(3):931-8, 11/2006.
28. Gunn GB, Villa RD, Sedler RR, Hardwicke F, Fornari GA, Mark RJ. Nasopharyngeal carcinoma metastasis to the pituitary gland: a case report and literature review. J Neurooncol 68(1):87-90, 5/2004. PMID: 15174525.

Invited Articles

1. Gunn GB, Frank SJ. Advances in Radiation Oncology for the Management of Oropharyngeal Tumors. Otolaryngol Clin North Am 46(4):629-43, 8/2013. e-Pub 6/19/2013. PMID: 23910474.

Book Chapters

1. Gunn GB and Garden AS. Postoperative intensity-modulated radiation therapy for head and neck cancers: A case-based review. In: Intensity-Modulated Radiation Therapy - Clinical Evidence and Techniques, First. Ed(s) Komaki R and Nishimura Y. Springer: Japan, 193-213, 2015.
2. Gunn GB, Blodgett TM. Thyroid. In: Radiation Oncology Imaging and Treatment, 1. Ed(s) DK Gaffney. Amirsys: Manitoba, Canada, 2-112, 2013. ISBN: 978-1-931884-70-9.
3. Kim ES, Gunn GB, William WN, Kies MS. Head and Neck Cancer. In: The M.D. Anderson Manual of Medical Oncology. 1, 2. Ed(s) Kantarjian HM, Wolff RA, Koller CA. McGraw Hill: New York, 385-405, 2011.
4. Gunn GB, Garden AS. Intensity-Modulated Radiation Therapy for Head and Neck Cancer: A Decade of Experience Demonstrates Improved Patient Outcomes. In: Radiation Medicine Rounds - Head and Neck Cancer. 2, 2. Ed(s) D Heron, R Tishler, C Thomas. Demos Medical, 2011. ISBN: 139781936287369.

Last updated: 6/8/2016